Clinical Trials Logo

Hydrocephalus, Communicating clinical trials

View clinical trials related to Hydrocephalus, Communicating.

Filter by:
  • None
  • Page 1

NCT ID: NCT05501002 Terminated - Hydrocephalus Clinical Trials

Pilot Study to Evaluate the CereVasc® eShunt® System in the Treatment of Communicating Hydrocephalus

Start date: September 15, 2022
Phase: N/A
Study type: Interventional

The purpose of this study will be to evaluate a novel, minimally invasive method of treating hydrocephalus in adults. The eShunt® System includes a proprietary eShunt® Delivery System and the eShunt® Implant, a permanent implant that is deployed in a mildly invasive, neuro-interventional procedure. The eShunt® Implant is designed to drain excess cerebrospinal fluid (CSF) from the intracranial subarachnoid space (SAS) into the venous system.

NCT ID: NCT04758611 Recruiting - Hydrocephalus Clinical Trials

The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)

ETCHES I
Start date: October 1, 2020
Phase: N/A
Study type: Interventional

The eShuntâ„¢ System is a minimally invasive method of treating communicating hydrocephalus. The eShunt System includes a proprietary eShunt Delivery System and the eShunt Implant, a permanent implant deployed in a minimally invasive, neuro-interventional procedure. The eShunt Implant is designed to drain excess cerebrospinal fluid (CSF) from the intracranial subarachnoid space (SAS) into the venous system.